Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The designation "Inhibitor 2 of protein phosphatase 2A" appears to refer to an inhibitory protein that regulates PP2A activity, rather than a target molecule itself. The provided search results do not contain specific information about a protein formally designated as "Inhibitor 2 of protein phosphatase 2A." While Protein Phosphatase 2A (PP2A) is a serine/threonine phosphatase composed of a scaffolding A subunit, a catalytic C subunit, and regulatory B subunits[2][3], and is known to be regulated by various mechanisms including post-translational modifications and endogenous inhibitory proteins like FAM122A[8], no specific protein called "Inhibitor 2" was found in the search results. This component is considered an endogenous regulatory protein, not a therapeutic target in the conventional sense. PP2A itself is the actual target of therapeutic interest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inhibitor 2 of protein phosphatase 2A.